Effectiveness case of Jidabokuippo (traditional Japanese Kampo medicine) on pain, venous thrombosis, and subcutaneous hematoma after percutaneous femoral catheterization in a hemodialysis patient. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Wada, Kentaro; Uchida, Haruhito; Wada, Yuko
• Is Part Of: Renal replacement therapy. Volume 3:Issue 1(2017)
• Page Start: 1
• Page End: 5
• Publication Date: 2017-12
• Subjects: Pain -- Thrombosis -- Hematoma -- Catheterization -- Hemodialysis -- Jidabokuippo; Kidneys -- Diseases -- Periodicals; Acute renal failure -- Treatment -- Periodicals; Kidneys -- Transplantation -- Periodicals; Hemodialysis -- Periodicals; 616.61406
• DOI: 10.1186/s41100-016-0086-3
• Languages: English
• ISSNs: 2059-1381

Abstract

Abstract Background The authors herein report a case of pain, femoral vein thrombosis, and inguinal subcutaneous hematoma caused by percutaneous femoral vascular catheterization in a hemodialysis (HD) patient complicated with vascular access occlusion. The pain was well-controlled without using analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs). The thrombosis and hematoma increased in size and was also treated by conservative treatment using traditional Japanese Kampo medicine (jidabokuippo: JDI) to resolveoketsu : a sign of microcirculating disorder. JDI improves the blood circulation in the affected lesion and alleviates contusion-induced blood flow and repairs blood flow without forming thrombosis. These catheter-related complications were successfully treated by JDI. Case presentation A 41-year-old man under HD was admitted because of permanent vascular access failure. He had a history of side effects of gastrointestinal bleeding associated with use of NSAIDs and accompanied with femoral vein thrombosis and inguinal subcutaneous hematoma caused by percutaneous femoral vascular catheterization. The hematoma increased in size and was treated using JDI. In the present case, pain, venous thrombosis, and subcutaneous hematoma surprisingly improved with use of JDI in addition to combination therapy with anticoagulant (warfarin potassium) and antibiotic (meropenem hydrate), without using analgesics such as NSAIDs. Conclusions The present case indicated as follows: JDI controls the pain associated with hematoma without analgesics such as NSAIDs; JDI also has an effect of improving the complications associated with venous thrombosis and subcutaneous hematoma caused by catheterization in HD patients safely. JDI, one of Kampo drugs, has few side effects and can be used as needed.